BurnA
Senior Member
- Messages
- 2,087
Good point. They are getting those patients from the clinics used in the other multi-site study, and Dr Lapp has expressed a belief that a gentle form of GET "can be of great benefit".
Dr Lapp's clinic in North Carolina is the 3rd closest to the NIH out of the 7 clinics, after the clinics in New York and New Jersey. How many CF patients who find that GET is of "great benefit" will be sent to the NIH as potential patients? Will it be enough for the psychosomatic trio of investigators to pack the study with them?
Maybe the strategy should be to go after the referring clinicians list instead of Walitt?
NIH would probably be more amenable to that.